http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1821161-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_332cb20f6e6a250f83a839b08a7c07d6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-00 |
filingDate | 1988-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1993-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f281fe54c5ba991a9a5b689de0719c6 |
publicationDate | 1993-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-1821161-C |
titleOfInvention | Method of curing cavernous forms of nephrophthisis |
abstract | Usage: medicine, phthisiotri, for the treatment of cavernous forms of kidney tuberculosis. The inventive cavity is opened, the contents of the cavity are aspirated, cryothermal treatment of the surface of the cavity is carried out, cryothermal treatment is carried out before aspiration, and after aspiration the surface of the capsule cavity is blown: with an oxygen-ozone mixture and exposed to microwave radiation with a power of 70-80 W, and cryotherapy conducted to minus 60-70 °; C and heating to plus 42-45 ° C, blowing with an oxygen-ozone mixture is carried out at an ozone concentration. 1.08-1.2 mg / l at a flow rate of 2-3 l / min. EFFECT: invention allows to shorten the treatment period due to ablation. |
priorityDate | 1988-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.